According to these observations, it was concluded that anti-PD-1 blocking antibodies exert an anti-melanoma effect by two different mechanisms: triggering an immunologic response anti-tumor cells and inhibiting melanoma cell proliferation through the inhibition of melanoma PD-1+ cells [268]. Here, PDCD1 is linked to melanoma.